BGAI
BIO icon

Bruce G. Allen Investments’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bruce G. Allen Investments’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1
Closed -$244 – 1090
2025
Q1 		$244 Sell
1
-7
-88% -$2.11K ﹤0.01% 1042
2024
Q4 		$2.63K Hold
8
– – ﹤0.01% 663
2024
Q3 		$2.68K Sell
8
-3
-27% -$953 ﹤0.01% 664
2024
Q2 		$3K Sell
11
-33
-75% -$9.6K ﹤0.01% 635
2024
Q1 		$15.2K Hold
44
– – 0.01% 412
2023
Q4 		$14.2K Buy
+44
New +$13.8K 0.01% 420

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
FPA
First Pacific Advisors El Segundo, California $7.14B AUM 21.51% 1-Year Est. Return

Bruce G. Allen Investments's BIO Position: Q2 2025 in Review

Bruce G. Allen Investments sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2025, closing a stake of 1 share — an estimated $244 sold.

Bruce G. Allen Investments first reported a position in BIO in Q4 2023 and held it in 6 quarters. The position peaked at $15.2K in Q1 2024. 384 funds tracked by Wall St. Rank hold BIO as of Q2 2025.

  • Bruce G. Allen Investments reported no remaining Bio-Rad Laboratories Class A position as of Q2 2025 after selling out during the quarter.
  • Bruce G. Allen Investments sold 1 Bio-Rad Laboratories Class A share in Q2 2025, an estimated $244.
  • Bruce G. Allen Investments first reported a position in Bio-Rad Laboratories Class A in Q4 2023 and held it in 6 quarters.
  • Bruce G. Allen Investments's Bio-Rad Laboratories Class A position peaked at $15.2K in Q1 2024.
  • 384 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2025.

Based on Bruce G. Allen Investments's 13F filing for Q2 2025, filed 9 Jul 2025.